Neuropsychopharmacology
- AM6527, a neutral CB1 receptor antagonist, suppresses opioid taking and seeking, as well as cocaine seeking in rodents without aversive effects2 years ago
- The selective D3Receptor antagonist VK4-116 reverses loss of insight caused by self-administration of cocaine in rats2 years ago
- Author Correction: Sex differences in offspring risk and resilience following 11β-hydroxylase antagonism in a rodent model of maternal immune activation2 years ago
- The rostromedial tegmental nucleus gates fat overconsumption through ventral tegmental area output in male rats2 years ago
- Retraction Note: Association between neuromelanin-sensitive MRI signal and psychomotor slowing in late-life depression2 years ago
- Altered excitatory and inhibitory ionotropic receptor subunit expression in the cortical visuospatial working memory network in schizophrenia2 years ago
- Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC)2 years ago
Journal of Psychopharmacology
- Is psychedelic use associated with cancer?: Interrogating a half-century-old claim using contemporary population-level data3 years ago
- Dynamic modulation of inhibition ability following repeated exposures to morphine in macaque monkey3 years ago
- Can cannabis kill? Characteristics of deaths following cannabis use in England (1998–2020)3 years ago
- CB1 receptor signalling mediates cannabidiol-induced panicolytic-like effects and defensive antinociception impairment in mice threatened by Bothrops jararaca lancehead pit vipers3 years ago
- Alprazolam-related deaths in Scotland, 2004–20203 years ago
- The chronic effects of a combination of herbal extracts (Euphytose®) on psychological mood state and response to a laboratory stressor: A randomised, placebo-controlled, double blind study in healthy humans3 years ago
- Effects of CYP2D6*4 polymorphism on the steady-state concentration of paroxetine in patients diagnosed with depressive episode and comorbid alcohol use disorder3 years ago
European Neuropsychopharmacology
- Therapeutic inertia in psychiatry: Focus on practice-evidence gaps3 years ago
- Rates of psychotropic medicine prescribing in paediatric populations in Australian general practice from 2000-20163 years ago
- Effect of psychotropics on the risk of COVID-19 in Middle-Aged and Older Adults3 years ago
- Sexual orientation as an important factor in personalized medicine3 years ago
- Single dose S-ketamine rescues transcriptional dysregulation of Mtor and Nrp2 in the prefrontal cortex of FSL rats 1hour but not 14 days post dosing3 years ago
- Delay in pharmacological treatment of autistic children after recognition of the disorder3 years ago
- Ayahuasca’s therapeutic potential: What we know – and what not3 years ago
Psychopharmacology
- Effect of chronic delivery of the NOP/MOR partial agonist AT-201 and NOP antagonist J-113397 on heroin relapse in a rat model of opioid maintenance1 year ago
- Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders1 year ago
- Emerging roles of cannabinoid receptor CB2 receptor in the central nervous system: therapeutic target for CNS disorders1 year ago
- Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal1 year ago
- Elucidating the molecular symphony: unweaving the transcriptional & epigenetic pathways underlying neuroplasticity in opioid dependence and withdrawal1 year ago
- Efficacy of agomelatine on sleep disorders and lateral habenula neuronal activity in chronic restraint stress depression model mice1 year ago
- Efficacy of agomelatine on sleep disorders and lateral habenula neuronal activity in chronic restraint stress depression model mice1 year ago
International Journal of Neuropsychopharmacology
- Frequent vocalizations and deep brain stimulation-responsive hyperkinesia in a striatal disinhibition rat model for Tourette syndrome6 months ago
- Exploring the influence of synaptic density and anxiety on pain perception: evidence from a [11C]UCB-J positron emission tomography imaging study6 months ago
- NMDA receptor involvement in dopaminergic modulation of neuroplasticity induced by paired associative stimulation6 months ago
- Pharmacological modulation of directed network communication and neural hubs in action–effect integration6 months ago
- Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice7 months ago
- Acute effects of intranasal esketamine application on thalamic structures in healthy individuals7 months ago
- Inhibition of hippocampal or thalamic inputs to the nucleus accumbens reverses stress-induced alterations in dopamine system function7 months ago
Frontiers in Pharmacology
- Electroencephalographic insights into the pathophysiological mechanisms of emergence delirium in children and corresponding clinical treatment strategies1 year ago
- Corrigendum: Artemisinin reduces PTSD-like symptoms, improves synaptic plasticity, and inhibits apoptosis in rats subjected to single prolonged stress1 year ago
- Editorial: The GABAA receptor: a target of pharmacologically active molecules1 year ago
- Understanding copy number variations through their genes: a molecular view on 16p11.2 deletion and duplication syndromes1 year ago
- Pharmacovigilance of esketamine nasal spray: an analysis of the FDA adverse event reporting system database1 year ago
- Jingqianshu granules mitigates premenstrual depression by regulating orexin signaling1 year ago
- Characterizing defective lipid metabolism in the lateral septum of mice treated with olanzapine: implications for its side effects1 year ago
Translational Psychiatry
- The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: a multimodal PET and MRS imaging study9 months ago
- Increased odds of metabolic syndrome among adults with depressive symptoms or antidepressant use9 months ago
- Neurofind: using deep learning to make individualised inferences in brain-based disorders9 months ago
- The midline thalamic nucleus reuniens promotes compulsive-like grooming in rodents9 months ago
- Alzheimer’s disease with depression: clinical characteristics and potential mechanisms involving orexin and brain atrophy10 months ago
- Acylcarnitines metabolism in depression: association with diagnostic status, depression severity and symptom profile in the NESDA cohort10 months ago
- Social buffering during fear extinction rescues long-term trauma-induced memory and emotional behavioral alterations in rats10 months ago
Molecular Psychiatry
- A simple platelet biomarker is associated with symptom severity in major depressive disorder9 months ago
- Brain O-GlcNAcylation: Bridging physiological functions, disease mechanisms, and therapeutic applications9 months ago
- Paranodal instability driven by axonal mitochondrial accumulation in ischemic demyelination and cognitive decline9 months ago
- Quantitative trait loci mapping of circulating metabolites in cerebrospinal fluid to uncover biological mechanisms involved in brain-related phenotypes9 months ago
- Investigating dopaminergic abnormalities in schizophrenia and first-episode psychosis with normative modelling and multisite molecular neuroimaging9 months ago
- The case for hemispheric lateralization of the human amygdala in fear processing9 months ago
- Suspected autoimmune-mediated dissociative symptoms9 months ago
Nature Reviews Neuroscience
CNS Spectrum
- Ketamine in the Treatment of Delusions: A Review of the Evidence3 years ago
- Safety and efficacy of KarXT (Xanomeline Trospium) in Schizophrenia in the Phase 3, Randomized, Double-Blind, Placebo-Controlled EMERGENT-2 Trial3 years ago
- A 16-Week Open-Label Study of the Effects of Treatment With Pimavanserin on Activities of Daily Living in Subjects With Parkinson’s Disease Psychosis3 years ago
- Clinical Determinants, Patterns, and Outcomes of Antipsychotic Medication Prescribing in the Treatment of Schizophrenia and Schizoaffective Disorder: A Naturalistic Cohort Study3 years ago
- Pharmacokinetic Profile of Aripiprazole 2-Month Ready-to-Use 960 mg in Adult Patients With Schizophrenia or Bipolar I Disorder3 years ago
- Effect of Lumateperone (ITI-007) on Quality of Life and Functional Disability in the Treatment of Bipolar Depression3 years ago
- Anticholinergics Should Not Be Used to Treat Tardive Dyskinesia: Insights From an Expert Panel of Psychiatry and Neurology Healthcare Professionals3 years ago
Neuropharmacology
- Effects of genetic knockdown of the serotonin transporter on established L-DOPA-induced dyskinesia and gene expression in hemiparkinsonian rats1 year ago
- Mitochondrial DAMPs: Key Mediators in Neuroinflammation and Neurodegenerative Disease Pathogenesis1 year ago
- 20(R)-ginsenoside Rg3 protects against focal cerebral ischemia‒reperfusion injury by suppressing autophagy via PI3K/Akt/mTOR signaling pathway1 year ago
- The synthetic cannabinoid agonist WIN 55,212-2 reduces experimental pruritus via CB2 receptor activation1 year ago
- Gallic acid and Loganic acid attenuate amyloid-β oligomer-induced microglia damage via NF-КB signaling pathway1 year ago
- MRS3997, a dual adenosine A2A/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats.1 year ago
- Nicotine and a positive allosteric modulator of m1 muscarinic receptor increase NMDA/AMPA ratio in the hippocampus and medial prefrontal cortex1 year ago
Nature
- Too much social media gives AI chatbots ‘brain rot’1 month ago
- Please stay out of the abandoned buildings1 month ago
- Why India’s controversial ‘cloud seeding’ trial failed to make it rain1 month ago
- Forests’ misty breath sustains crops in distant lands1 month ago
- Secret route to warm cosmic ‘inflation’: the nuclear force1 month ago
- Artificial brains with less drain1 month ago
- Personalized gene editing helped one baby: can it be rolled out widely?1 month ago